ESCMID eLibrary
Search results
Icon explanation
Icon explanation
close
Abstract
ePoster
Handout
Image
Journal Article
Presentation
Video
Webcast
Found 20 results
-
P1828
In vitro activity of lefamulin against isolates commonly causing community-acquired bacterial pneumonia collected during the SENTRY surveillance programme 2017 in Europe
15 April 2019
Session: In vitro activity of investigational antibacterial agents
Relevance:100% -
P1823
In vitro activity of lefamulin against contemporary Staphylococcus aureus isolates from patients in Europe (SENTRY 2016)
23 April 2018
Session: Resistance in various Gram-positives
Relevance:100% -
P0619
In Vitro activity of lefamulin against bacterial pathogens collected from patients with community- or hospital-acquired respiratory tract infections: 2016 SENTRY data from Europe
22 April 2018
Session: Community-acquired respiratory infections
Relevance:100% -
P0250
In vitro bactericidal activity of lefamulin against Streptococcus pneumoniae isolates
21 April 2018
Session: Pre-clinical PK/PD
Relevance:100% -
P1334
In vitro activity of lefamulin against a global collection of respiratory pathogens from paediatric patients from the 2015 SENTRY programme
24 April 2017
Session: Various agents against Gram-positive bacteria
Relevance:100%
-
P1333
In Vitro Activity of Lefamulin against S. aureus Collected from Hospitalized Patients with Bacterial Pneumonia in Europe
24 April 2017
Session: Various agents against Gram-positive bacteria
Relevance:100% -
P1332
In Vitro Activity of Lefamulin against Staphylococccus aureus from Hospital-Acquired Pneumonia (HAP) and Community-Acquired Pneumonia (CAP) Patients in Europe
24 April 2017
Session: Various agents against Gram-positive bacteria
Relevance:100%
-
P1335
Lefamulin is highly active in-vitro against multi-drug-resistant mycoplasma genitalium strains
24 April 2017
Session: Various agents against Gram-positive bacteria
Relevance:100% -
P1331
In vitro activity of lefamulin against bacterial pathogens commonly causing community-acquired bacterial pneumonia (CAP): 2015 SENTRY data from Europe
24 April 2017
Session: Various agents against Gram-positive bacteria
Relevance:100%
-
EP0405
Lefamulin selectively inhibits bacterial protein synthesis
23 April 2017
Session: New antibiotics - new approaches
Relevance:100%
